Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 1 of 62 PageID #: 2452
`Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 1 of 62 PagelD #: 2452
`
`APPENDIX C
`APPENDIX C
`
`

`

`Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 2 of 62 PageID #: 2453
`Case 1:24-CRSPPEARERDSHEATHRHATOREIPARED # 2453
`ON MULTIDISTRICT LITIGATION
`
`MDL No. 3103.
`
`& Title - IN RE: Aflibercept PatentLitigation
`
`NOTICE OF APPEARANCE
`
`(Appearances should only be entered in compliance with Rule 4.1(c).
`
`PARTIES REPRESENTED(indicate plaintiff or defendant(i.e. Plaintiff Bob Jones)-If representation
`includes more than one party, attach a separatelist.)
`
`See attachedlist.
`
`SHORT CASE CAPTION(s) (Include District and Civil Action No.(i.e. Jones v. Smith Corp., et al., D.
`Delaware, 1:14-586)—If party representation includes more than onecase, attach a schedule of actions)
`NOTE: Include only actions in which you are entering an Appearance.
`
`See attachedlist.
`
`In compliance with Rule 4.1(c), R.P.J.P.M.L., 199 F.R.D. 425, 431 (2001), the following designated
`attorney is authorized to receive service ofall pleadings, notices, orders, and other papersrelating to practice before
`the United States Judicial Panel on Multidistrict Litigation on behalf of the plaintiff(s)/ defendant(s) indicated.
`I am
`awarethat only one attorney can be designated for each party.
`
`
`
`1/26/24 /s/ Deanne M. Mazzochi
`
`Date
`
`Signature of Attorney or Designee
`
`Nameand Addressof Designated Attorney: Deanne M. Mazzochi
`6 West Hubbard Street
`
`Chicago,Illinois 60654
`
`Telephone No.: 312-527-2157
`
`Fax No.: 312-527-4205
`
`Email Address: dmazzochi@rmmslegal.com
`
`Instructions:
`
`1. From the JPML home page, download Notice of Appearance.Fill out form and save in .pdf format. (All documents filed with the Judicial Panel must be in PDF Format.)
`
`The Appearance Form isto be filed as the main PDF document. Any documents submitted with the Appearance Form are attachments.
`
`2. Select MDLfrom the menubar at the top ofthe ECF screen.
`
`3. Click on Notices. Select the appropriate Notice ofAppearance. Select Next.
`
`4. Enter the three or four digit MDL number (ex. 875). Select Next.
`
`5. Verify MDL number,if correct Select Next.
`
`6. Choose the case(s) for which the Appearance is being filed. Select Next.
`
`7. Select Party. Select next twice.
`
`8. Upload the Appearance Form as the Main document and all other documentsas attachments. Be sure to choose a category and description. Select the document to which
`
`the Appearance relates. (N ote: Appearances filed in new litigations will be linked to the initial Motion for Transfer and Appearances filed in transferred litigations should be
`linked to the Conditional Transfer Order (CTO).
`
`9. Select the next button and verify docket text. If correct continue to select next to complete the transaction.
`
`JPML Form 18
`
`

`

`
`
`Case MDL No. 3103 Document 17 Filed 01/26/24 Page 2 of 2Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 3 of 62 PageID #: 2454
`
`PARTIES REPRESENTED (indicate plaintiff or defendant (i.e. Plaintiff Bob Jones)–If
`representation includes more than one party, attach a separate list.)
`
`Defendant Biocon Biologics Inc., Defendant Mylan Pharmaceuticals Inc.
`
`SHORT CASE CAPTION(s) (Include District and Civil Action No. (i.e. Jones v. Smith Corp.,
`et al., D. Delaware, 1:14-586)–If party representation includes more than one case, attach a
`schedule of actions)
`
`Regeneron Pharm., Inc., v. Mylan Pharm. Inc. et al., N.D. W. Va., No. 1:22-cv-00061-TSK-JPM
`
`

`

`
`
`Case MDL No. 3103 Document 17-1 Filed 01/26/24 Page 1 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 4 of 62 PageID #: 2455
`
`BEFORE THE UNITED STATES JUDICIAL PANEL
`ON MULTIDISTRICT LITIGATION
`
`
`In re Aflibercept Patent Litigation
`
`
` MDL No. 3103
`
`PROOF OF SERVICE
`In compliance with Rule 4.1(a) of the Rules of Procedure for the United States Judicial
`
`
`
`
`Panel on Multidistrict Litigation, I hereby certify that copies of the foregoing Notice of Appearance
`
`for Defendant Biocon Biologics Inc. and Defendant Mylan Pharmaceuticals Inc., Corporate
`
`Disclosure Statement for Defendant Biocon Biologics Inc., Corporate Disclosure Statement for
`
`Defendant Mylan Pharmaceuticals Inc., and Proof of Service were served by Email on January 26,
`
`2024 to the following:
`
`Counsel for Plaintiff Regeneron Pharmaceuticals Inc. (Served via Email)
`
`
`David I. Berl
`Ellen E. Oberwetter
`Thomas S. Fletcher
`Andrew V. Trask
`Teagan J. Gregory
`Shaun P. Mahaffy
`Kathryn S. Kayali
`Arthur J. Argall, III
`Adam Pan
`Rebecca A. Carter
`Haylee Bernal Anderson
`Renee M. Griffin
`Jennalee Beazley
`Rhochelle Krawetz
`Sean M. Douglass
`Nicholas Jordan
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, SW
`Washington, DC 20024
`dberl@wc.com
`eoberwetter@wc.com
`tfletcher@wc.com
`
`

`

`
`
`Case MDL No. 3103 Document 17-1 Filed 01/26/24 Page 2 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 5 of 62 PageID #: 2456
`
`
`
`atrask@wc.com
`tgregory@wc.com
`smahaffy@wc.com
`kkayali@wc.com
`aargall@wc.com
`apan@wc.com
`rebeccacarter@wc.com
`handerson@wc.com
`rgriffin@wc.com
`jbeazley@wc.com
`rkrawetz@wc.com
`sdouglass@wc.com
`njordan@wc.com
`
`Elizabeth S. Weiswasser
`Anish R. Desai
`Natalie C. Kennedy
`Tom Yu
`Yi Zhang
`Kathryn Leicht
`Rocco Recce
`Zhen Lin
`Kellie Van Beck
`Jennifer Melien Brooks Crozier
`WEIL GOTSHAL & MANGES LLP
`767 5th Avenue
`New York, NY 10153
`Elizabeth.Weiswasser@weil.com
`Anish.Desai@weil.com
`Natalie.Kennedy@weil.com
`Tom.Yu@weil.com
`Yi.Zhang@weil.com
`Kathryn.Leicht@weil.com
`Rocco.Recce@weil.com
`Zhen.Lin@weil.com
`Kellie.VanBeck@weil.com
`Jennifer.Crozier@weil.com
`
`Christopher M. Pepe
`Priyata Y. Patel
`Matthew Sieger
`WEIL GOTSHAL & MANGES LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`Christopher.Pepe@weil.com
`Priyata.Patel@weil.com
`
`

`

`
`
`Case MDL No. 3103 Document 17-1 Filed 01/26/24 Page 3 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 6 of 62 PageID #: 2457
`
`Matthew.Seiger@weil.com
`
`Andrew E. Goldsmith
`Jacob E. Hartman
`Evan T. Leo
`Mary Charlotte Y. Carroll
`Sven E. Henningson, III
`Grace W. Knofczynski
`KELLOGG, HANSEN, TODD, FIGEL & FREDERICK, P.L.L.C.
`1615 M Street, NW, Suite 400
`Washington, DC 20036
`agoldsmith@kellogghansen.com
`eleo@kellogghansen.com
`jhartman@kellogghansen.com
`mcarroll@kellogghansen.com
`shenningson@kellogghansen.com
`gknofczynski@kellogghansen.com
`
`Michael W. Carey
`Steven R. Ruby
`David R. Pogue
`Raymond S. Franks, II
`S. Benjamin Bryant
`CAREY DOUGLAS KESSLER & RUBY, PLLC
`707 Virginia Street East
`901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25353
`mwcarey@cdkrlawfirm.com
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`rfranks@cdkrlaw.com
`sbbryant@cdkrlaw.com
`
`Tony Bisconti
`BIENERT KATZMAN LITTRELL WILLIAMS LLP
`903 Calle Amanecer, Suite 350,
`San Clemente, CA 92673
`tbisconti@bklwlaw.com
`
`
`Counsel for Defendants by Proceeding (Served via Email) 1
`
`
`
`1 Counsel appearing on behalf of Defendant Biocon Biologics Inc. and Defendant Mylan
`Pharmaceuticals Inc. in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.,
`N.D. W. Va., C.A. No. 1:22-cv-00061-TSK-JPM are included in the signature block.
`
`

`

`
`
`Case MDL No. 3103 Document 17-1 Filed 01/26/24 Page 4 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 7 of 62 PageID #: 2458
`
`Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.,
`N.D. W. Va., C.A. No. 1:22-cv-00061-TSK-JPM
`
`
`Counsel for Defendant-Intervenor Amgen USA, Inc.
`
`
`John H. Tinney, Jr.
`HENDRICKSON & LONG, PLLC
`214 Capitol Street
`P.O. Box 11070 Charleston, WV 25301
`jtinney@handl.com
`
`
`Counsel for Defendant-Intervenor Celltrion, Inc.
`
`
`Laura C. Davis.
`MANCHIN FERRETTI, PLLC
`408 West King Street
`Martinsburg, WV 25401
`ldavis@wvjusticelawyers.com
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.,
`N.D. W. Va., C.A. No. 1:23-cv-00089-TSK
`
`
`Counsel for Defendant Celltrion, Inc.
`
`
`Robert Cerwinski
`Cindy Chang
`Michael Cottler
`Lora Green
`David Kim
`Brigid Morris
`Aviv Zalcenstein
`GEMINI LAW LLP
`40 W. 24th Street, Suite 6N
`New York, NY 10010
`rcerwinski@geminilaw.com
`cchang@geminilaw.com
`mcottler@geminilaw.com
`lgreen@geminilaw.com
`dkim@geminilaw.com
`bmorris@geminilaw.com
`azalcenstein@geminilaw.com
`
`Andrew C. Robey
`Carl Winfield Shaffer
`Max C. Gottlieb
`Michael B. Hissam
`
`

`

`
`
`Case MDL No. 3103 Document 17-1 Filed 01/26/24 Page 5 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 8 of 62 PageID #: 2459
`
`HISSAM FORMAN DONOVAN RITCHIE PLLC
`707 Virginia Street, East, Suite 260
`Post Office Box 3983
`Charleston, WV 25301
`arobey@hfdrlaw.com
`cshaffer@hfdrlaw.com
`mgottlieb@hfdrlaw.com
`mhissam@hfdrlaw.com
`
`Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.,
`N.D. W. Va., C.A. No. 1:23-cv-00094-TSK & N.D. W. Va., C.A. No. 1:23-cv-00106-TSK
`
`
`
`
`
`
`Counsel for Defendant Samsung Bioepis Co. Ltd.
`
`
`Chad L. Taylor
`Frank E. Simmerman, Jr.
`Frank Edward Simmerman, III
`SIMMERMAN LAW OFFICE PLLC
`254 E Main St Clarksburg, WV 26301
`clt@simmermanlaw.com
`fes@simmermanlaw.com
`trey@simmermanlaw.com
`
`Laura L. Fairneny
`Matthew A. Traupman
`Raymond N. Nimrod
`Matthew D. Robson
`QUINN EMANUEL URQUHART & SULLIVAN, LLP
`51 Madison Avenue 22nd Floor
`New York, NY 10010
`laurafairneny@quinnemanuel.com
`matthewtraupman@quinnemanuel.com
`raynimrod@quinnemanuel.com
`matthewrobson@quinnemanuel.com
`
`Zachariah B. Summers
`QUINN EMANUEL URQUHART & SULLIVAN, LLP - LA
`865 S. Figueroa Street, 10th Floor
`Los Angeles, CA 90017
`zachsummers@quinnemanuel.com
`
`Sandra K. Law
`SCHRADER COMPANION DUFF & LAW, PLLC
`401 Main Street
`Wheeling, WV 26003
`skl@schraderlaw.com
`
`

`

`
`
`Case MDL No. 3103 Document 17-1 Filed 01/26/24 Page 6 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 9 of 62 PageID #: 2460
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Formycon AG,
`N.D. W. Va., C.A. No. 1:23-cv-00097-TSK
`
`
`Counsel for Defendant Formycon AG
`
`Bryant J. Spann
`M. David Griffith, Jr.
`THOMAS COMBS & SPANN, PLLC
`300 Summers Street, Suite 1380
`P.O. Box 3824
`Charleston, WV 25338-3824
`bspann@tcspllc.com
`dgriffith@tcspllc.com
`
`Louis E. Fogel
`Shaun M. Van Horn
`Terri L. Mascherin
`JENNER & BLOCK LLP - CHICAGO
`353 North Clark Street
`Chicago, IL 60654
`lfogel@jenner.com
`SVanHorn@jenner.com
`tmascherin@jenner.com
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Amgen Inc,
`C.D. Cal., C.A. No. 2:24-cv-00264
`
`
`Counsel for Defendant Amgen Inc.
`
`
`Shawn Scott Ledingham, Jr.
`PROSKAUER ROSE LLP
`2029 Century Park East Suite 2400
`Los Angeles, CA 90067-3010
`310-284-5659
`sledingham@proskauer.com
`
`Siegmund Y Gutman
`PROSKAUER ROSE LLP
`2029 Century Park East 24th Floor
`Los Angeles, CA 90067
`sgutman@proskauer.com
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 17-1 Filed 01/26/24 Page 7 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 10 of 62 PageID #: 2461
`
`Date: January 26, 2024
`
`
`
`Garrett Matthew Spiker
`Gordon H. Copland
`John D. Pizzo
`William J O'Brien
`Stephenee Raychel Gandee
`STEPTOE & JOHNSON PLLC
`400 White Oaks Boulevard
`Bridgeport, WV 26330
`(304) 933-8162
`garrett.spiker@steptoe-johnson.com
`Gordon.Copland@steptoe-johnson.com
`john.pizzo@steptoe-johnson.com
`William.Obrien@Steptoe-Johnson.com
`stephenee.gandee@steptoe-johnson.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Deanne M. Mazzochi
`Deanne M. Mazzochi
`William A. Rakoczy
`Heinz J. Salmen
`Eric R. Hunt
`Neil B. McLaughlin
`Lauren M. Lesko
`L. Scott Beall
`Thomas H. Ehrich
`Steven J. Birkos
`Katie A. Boda
`Abraham J. Varon
`Jake R. Ritthamel
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 W. Hubbard St.
`Chicago, IL 60654
`(312) 527-2157 (phone)
`(312) 527-4205 (facsimile)
`dmazzochi@rmmslegal.com
`wrakoczy@rmmslegal.com
`hsalmen@rmmslegal.com
`ehunt@rmmslegal.com
`nmclaughlin@rmmslegal.com
`llesko@rmmslegal.com
`sbeall@rmmslegal.com
`tehrich@rmmslegal.com
`sbirkos@rmmslegal.com
`kboda@rmmslegal.com
`avaron@rmmslegal.com
`jritthamel@rmmslegal.com
`
`Attorneys for Defendants Biocon Biologics Inc. and
`Mylan Pharmaceuticals Inc
`
`
`
`
`

`

`Case MDL No. 3103 Document 18 Filed 01/26/24 Page 1 of 1Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 11 of 62 PageID #: 2462
`
`UNITED STATES JUDICIAL PANEL ON MULTIDISTRICT LITIGATION
`
`MDL No. _____________ & TITLE - IN RE: __________________________________
`
`Case Caption (Include Plaintiff, District, and Civil Action No.) (attach list if necessary):
`
`_________________________________________________________________
`
`CORPORATE DISCLOSURE STATEMENT
`
`The undersigned counsel for ___________________________, (attach list if necessary) certifies that this
`party is a non-governmental corporate party and that:
`
`This party's parent corporation(s) are listed below:
`
`The following publicly-held corporation(s) own 10% or more of the party's stock (attach list if
`necessary):
`
`OR
`
`This party does not have any parent corporations; and no publicly-held corporation owns 10% or
`more of the party's stock.
`
`_____________________________ __________________________________
` Signature of Attorney
` Name of Firm
`
`___________________________ ___________________________________
` Address
` City/State/Zip Code
`
`Date _____________________
`
`Instructions:
`
`1. Download the form. Fill out the form and save as a PDF document. All documents filed with the Judicial Panel should be in PDF Format including attachments and
`exhibits. The Corporate Disclosure Statement is to be filed as a separate document. Any documents submitted with the Corporate Disclosure Statement are attachments.
`2. Select MDL from the menu bar at the top of the ECF screen.
`3. Click on Corporate Disclosure Statement. Select Next.
`4. Enter the three or four digit number (without the MDL letters) and click the Find This Case button.
`5. If this is the correct MDL No., select next. Also, select next for the following screen.
`6. Choose the cases for which the Disclosure Statement is being filed.
`7. Select the party filing the Disclosure Statement
`8. Select the document to which the Corporate Disclosure relates. (Note: Disclosures filed in new litigations will be linked to the initial Motion for Transfer and Disclosures
`filed in transferred litigations should be linked to the Conditional Transfer Order (CTO) or Motion and Brief to Vacate CTO).
`9. Upload the Corporate Disclosure Form and any attachments as a PDF document.
`10. Submit the Disclosure Statement by selecting the Next button.
`
`3103
`
`Aflibercept Patent Litigation
`
`Regeneron Pharm., Inc., v. Mylan Pharm. Inc. et al., N.D. W. Va., No. 1:22-cv-00061-TSK-JPM
`
`Mylan Pharmaceuticals Inc.
`
`4
`
`4
`
`Mylan Inc; Viatris Inc., a publicly traded company.
`
`Viatris Inc.
`
`/s/ Deanne M. Mazzochi
`
`Rakoczy Molino Mazzochi Siwik LLP
`
`6 West Hubbard Street
`
`Chicago, Illinois 60654
`
`January 26, 2024
`
`

`

`
`
`Case MDL No. 3103 Document 18-1 Filed 01/26/24 Page 1 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 12 of 62 PageID #: 2463
`
`BEFORE THE UNITED STATES JUDICIAL PANEL
`ON MULTIDISTRICT LITIGATION
`
`
`In re Aflibercept Patent Litigation
`
`
` MDL No. 3103
`
`PROOF OF SERVICE
`In compliance with Rule 4.1(a) of the Rules of Procedure for the United States Judicial
`
`
`
`
`Panel on Multidistrict Litigation, I hereby certify that copies of the foregoing Notice of Appearance
`
`for Defendant Biocon Biologics Inc. and Defendant Mylan Pharmaceuticals Inc., Corporate
`
`Disclosure Statement for Defendant Biocon Biologics Inc., Corporate Disclosure Statement for
`
`Defendant Mylan Pharmaceuticals Inc., and Proof of Service were served by Email on January 26,
`
`2024 to the following:
`
`Counsel for Plaintiff Regeneron Pharmaceuticals Inc. (Served via Email)
`
`
`David I. Berl
`Ellen E. Oberwetter
`Thomas S. Fletcher
`Andrew V. Trask
`Teagan J. Gregory
`Shaun P. Mahaffy
`Kathryn S. Kayali
`Arthur J. Argall, III
`Adam Pan
`Rebecca A. Carter
`Haylee Bernal Anderson
`Renee M. Griffin
`Jennalee Beazley
`Rhochelle Krawetz
`Sean M. Douglass
`Nicholas Jordan
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, SW
`Washington, DC 20024
`dberl@wc.com
`eoberwetter@wc.com
`tfletcher@wc.com
`
`

`

`
`
`Case MDL No. 3103 Document 18-1 Filed 01/26/24 Page 2 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 13 of 62 PageID #: 2464
`
`
`
`atrask@wc.com
`tgregory@wc.com
`smahaffy@wc.com
`kkayali@wc.com
`aargall@wc.com
`apan@wc.com
`rebeccacarter@wc.com
`handerson@wc.com
`rgriffin@wc.com
`jbeazley@wc.com
`rkrawetz@wc.com
`sdouglass@wc.com
`njordan@wc.com
`
`Elizabeth S. Weiswasser
`Anish R. Desai
`Natalie C. Kennedy
`Tom Yu
`Yi Zhang
`Kathryn Leicht
`Rocco Recce
`Zhen Lin
`Kellie Van Beck
`Jennifer Melien Brooks Crozier
`WEIL GOTSHAL & MANGES LLP
`767 5th Avenue
`New York, NY 10153
`Elizabeth.Weiswasser@weil.com
`Anish.Desai@weil.com
`Natalie.Kennedy@weil.com
`Tom.Yu@weil.com
`Yi.Zhang@weil.com
`Kathryn.Leicht@weil.com
`Rocco.Recce@weil.com
`Zhen.Lin@weil.com
`Kellie.VanBeck@weil.com
`Jennifer.Crozier@weil.com
`
`Christopher M. Pepe
`Priyata Y. Patel
`Matthew Sieger
`WEIL GOTSHAL & MANGES LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`Christopher.Pepe@weil.com
`Priyata.Patel@weil.com
`
`

`

`
`
`Case MDL No. 3103 Document 18-1 Filed 01/26/24 Page 3 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 14 of 62 PageID #: 2465
`
`Matthew.Seiger@weil.com
`
`Andrew E. Goldsmith
`Jacob E. Hartman
`Evan T. Leo
`Mary Charlotte Y. Carroll
`Sven E. Henningson, III
`Grace W. Knofczynski
`KELLOGG, HANSEN, TODD, FIGEL & FREDERICK, P.L.L.C.
`1615 M Street, NW, Suite 400
`Washington, DC 20036
`agoldsmith@kellogghansen.com
`eleo@kellogghansen.com
`jhartman@kellogghansen.com
`mcarroll@kellogghansen.com
`shenningson@kellogghansen.com
`gknofczynski@kellogghansen.com
`
`Michael W. Carey
`Steven R. Ruby
`David R. Pogue
`Raymond S. Franks, II
`S. Benjamin Bryant
`CAREY DOUGLAS KESSLER & RUBY, PLLC
`707 Virginia Street East
`901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25353
`mwcarey@cdkrlawfirm.com
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`rfranks@cdkrlaw.com
`sbbryant@cdkrlaw.com
`
`Tony Bisconti
`BIENERT KATZMAN LITTRELL WILLIAMS LLP
`903 Calle Amanecer, Suite 350,
`San Clemente, CA 92673
`tbisconti@bklwlaw.com
`
`
`Counsel for Defendants by Proceeding (Served via Email) 1
`
`
`
`1 Counsel appearing on behalf of Defendant Biocon Biologics Inc. and Defendant Mylan
`Pharmaceuticals Inc. in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.,
`N.D. W. Va., C.A. No. 1:22-cv-00061-TSK-JPM are included in the signature block.
`
`

`

`
`
`Case MDL No. 3103 Document 18-1 Filed 01/26/24 Page 4 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 15 of 62 PageID #: 2466
`
`Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.,
`N.D. W. Va., C.A. No. 1:22-cv-00061-TSK-JPM
`
`
`Counsel for Defendant-Intervenor Amgen USA, Inc.
`
`
`John H. Tinney, Jr.
`HENDRICKSON & LONG, PLLC
`214 Capitol Street
`P.O. Box 11070 Charleston, WV 25301
`jtinney@handl.com
`
`
`Counsel for Defendant-Intervenor Celltrion, Inc.
`
`
`Laura C. Davis.
`MANCHIN FERRETTI, PLLC
`408 West King Street
`Martinsburg, WV 25401
`ldavis@wvjusticelawyers.com
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.,
`N.D. W. Va., C.A. No. 1:23-cv-00089-TSK
`
`
`Counsel for Defendant Celltrion, Inc.
`
`
`Robert Cerwinski
`Cindy Chang
`Michael Cottler
`Lora Green
`David Kim
`Brigid Morris
`Aviv Zalcenstein
`GEMINI LAW LLP
`40 W. 24th Street, Suite 6N
`New York, NY 10010
`rcerwinski@geminilaw.com
`cchang@geminilaw.com
`mcottler@geminilaw.com
`lgreen@geminilaw.com
`dkim@geminilaw.com
`bmorris@geminilaw.com
`azalcenstein@geminilaw.com
`
`Andrew C. Robey
`Carl Winfield Shaffer
`Max C. Gottlieb
`Michael B. Hissam
`
`

`

`
`
`Case MDL No. 3103 Document 18-1 Filed 01/26/24 Page 5 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 16 of 62 PageID #: 2467
`
`HISSAM FORMAN DONOVAN RITCHIE PLLC
`707 Virginia Street, East, Suite 260
`Post Office Box 3983
`Charleston, WV 25301
`arobey@hfdrlaw.com
`cshaffer@hfdrlaw.com
`mgottlieb@hfdrlaw.com
`mhissam@hfdrlaw.com
`
`Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.,
`N.D. W. Va., C.A. No. 1:23-cv-00094-TSK & N.D. W. Va., C.A. No. 1:23-cv-00106-TSK
`
`
`
`
`
`
`Counsel for Defendant Samsung Bioepis Co. Ltd.
`
`
`Chad L. Taylor
`Frank E. Simmerman, Jr.
`Frank Edward Simmerman, III
`SIMMERMAN LAW OFFICE PLLC
`254 E Main St Clarksburg, WV 26301
`clt@simmermanlaw.com
`fes@simmermanlaw.com
`trey@simmermanlaw.com
`
`Laura L. Fairneny
`Matthew A. Traupman
`Raymond N. Nimrod
`Matthew D. Robson
`QUINN EMANUEL URQUHART & SULLIVAN, LLP
`51 Madison Avenue 22nd Floor
`New York, NY 10010
`laurafairneny@quinnemanuel.com
`matthewtraupman@quinnemanuel.com
`raynimrod@quinnemanuel.com
`matthewrobson@quinnemanuel.com
`
`Zachariah B. Summers
`QUINN EMANUEL URQUHART & SULLIVAN, LLP - LA
`865 S. Figueroa Street, 10th Floor
`Los Angeles, CA 90017
`zachsummers@quinnemanuel.com
`
`Sandra K. Law
`SCHRADER COMPANION DUFF & LAW, PLLC
`401 Main Street
`Wheeling, WV 26003
`skl@schraderlaw.com
`
`

`

`
`
`Case MDL No. 3103 Document 18-1 Filed 01/26/24 Page 6 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 17 of 62 PageID #: 2468
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Formycon AG,
`N.D. W. Va., C.A. No. 1:23-cv-00097-TSK
`
`
`Counsel for Defendant Formycon AG
`
`Bryant J. Spann
`M. David Griffith, Jr.
`THOMAS COMBS & SPANN, PLLC
`300 Summers Street, Suite 1380
`P.O. Box 3824
`Charleston, WV 25338-3824
`bspann@tcspllc.com
`dgriffith@tcspllc.com
`
`Louis E. Fogel
`Shaun M. Van Horn
`Terri L. Mascherin
`JENNER & BLOCK LLP - CHICAGO
`353 North Clark Street
`Chicago, IL 60654
`lfogel@jenner.com
`SVanHorn@jenner.com
`tmascherin@jenner.com
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Amgen Inc,
`C.D. Cal., C.A. No. 2:24-cv-00264
`
`
`Counsel for Defendant Amgen Inc.
`
`
`Shawn Scott Ledingham, Jr.
`PROSKAUER ROSE LLP
`2029 Century Park East Suite 2400
`Los Angeles, CA 90067-3010
`310-284-5659
`sledingham@proskauer.com
`
`Siegmund Y Gutman
`PROSKAUER ROSE LLP
`2029 Century Park East 24th Floor
`Los Angeles, CA 90067
`sgutman@proskauer.com
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 18-1 Filed 01/26/24 Page 7 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 18 of 62 PageID #: 2469
`
`Date: January 26, 2024
`
`
`
`Garrett Matthew Spiker
`Gordon H. Copland
`John D. Pizzo
`William J O'Brien
`Stephenee Raychel Gandee
`STEPTOE & JOHNSON PLLC
`400 White Oaks Boulevard
`Bridgeport, WV 26330
`(304) 933-8162
`garrett.spiker@steptoe-johnson.com
`Gordon.Copland@steptoe-johnson.com
`john.pizzo@steptoe-johnson.com
`William.Obrien@Steptoe-Johnson.com
`stephenee.gandee@steptoe-johnson.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Deanne M. Mazzochi
`Deanne M. Mazzochi
`William A. Rakoczy
`Heinz J. Salmen
`Eric R. Hunt
`Neil B. McLaughlin
`Lauren M. Lesko
`L. Scott Beall
`Thomas H. Ehrich
`Steven J. Birkos
`Katie A. Boda
`Abraham J. Varon
`Jake R. Ritthamel
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 W. Hubbard St.
`Chicago, IL 60654
`(312) 527-2157 (phone)
`(312) 527-4205 (facsimile)
`dmazzochi@rmmslegal.com
`wrakoczy@rmmslegal.com
`hsalmen@rmmslegal.com
`ehunt@rmmslegal.com
`nmclaughlin@rmmslegal.com
`llesko@rmmslegal.com
`sbeall@rmmslegal.com
`tehrich@rmmslegal.com
`sbirkos@rmmslegal.com
`kboda@rmmslegal.com
`avaron@rmmslegal.com
`jritthamel@rmmslegal.com
`
`Attorneys for Defendants Biocon Biologics Inc. and
`Mylan Pharmaceuticals Inc
`
`
`
`
`

`

`Case MDL No. 3103 Document 19 Filed 01/26/24 Page 1 of 1Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 19 of 62 PageID #: 2470
`
`UNITED STATES JUDICIAL PANEL ON MULTIDISTRICT LITIGATION
`
`MDL No. _____________ & TITLE - IN RE: __________________________________
`
`Case Caption (Include Plaintiff, District, and Civil Action No.) (attach list if necessary):
`
`_________________________________________________________________
`
`CORPORATE DISCLOSURE STATEMENT
`
`The undersigned counsel for ___________________________, (attach list if necessary) certifies that this
`party is a non-governmental corporate party and that:
`
`This party's parent corporation(s) are listed below:
`
`The following publicly-held corporation(s) own 10% or more of the party's stock (attach list if
`necessary):
`
`OR
`
`This party does not have any parent corporations; and no publicly-held corporation owns 10% or
`more of the party's stock.
`
`_____________________________ __________________________________
` Signature of Attorney
` Name of Firm
`
`___________________________ ___________________________________
` Address
` City/State/Zip Code
`
`Date _____________________
`
`Instructions:
`
`1. Download the form. Fill out the form and save as a PDF document. All documents filed with the Judicial Panel should be in PDF Format including attachments and
`exhibits. The Corporate Disclosure Statement is to be filed as a separate document. Any documents submitted with the Corporate Disclosure Statement are attachments.
`2. Select MDL from the menu bar at the top of the ECF screen.
`3. Click on Corporate Disclosure Statement. Select Next.
`4. Enter the three or four digit number (without the MDL letters) and click the Find This Case button.
`5. If this is the correct MDL No., select next. Also, select next for the following screen.
`6. Choose the cases for which the Disclosure Statement is being filed.
`7. Select the party filing the Disclosure Statement
`8. Select the document to which the Corporate Disclosure relates. (Note: Disclosures filed in new litigations will be linked to the initial Motion for Transfer and Disclosures
`filed in transferred litigations should be linked to the Conditional Transfer Order (CTO) or Motion and Brief to Vacate CTO).
`9. Upload the Corporate Disclosure Form and any attachments as a PDF document.
`10. Submit the Disclosure Statement by selecting the Next button.
`
`3103
`
`Aflibercept Patent Litigation
`
`Regeneron Pharm., Inc., v. Mylan Pharm. Inc. et al., N.D. W. Va., No. 1:22-cv-00061-TSK-JPM
`
`Biocon Biologics Inc.
`
`4
`
`4
`
`Biocon Biologics UK Limited; Biocon Biologics Limited; Biocon Limited, a publicly traded company
`
`Biocon Limited
`
`/s/ Deanne M. Mazzochi
`
`Rakoczy Molino Mazzochi Siwik LLP
`
`6 West Hubbard Street
`
`Chicago, Illinois 60654
`
`January 26, 2024
`
`

`

`
`
`Case MDL No. 3103 Document 19-1 Filed 01/26/24 Page 1 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 20 of 62 PageID #: 2471
`
`BEFORE THE UNITED STATES JUDICIAL PANEL
`ON MULTIDISTRICT LITIGATION
`
`
`In re Aflibercept Patent Litigation
`
`
` MDL No. 3103
`
`PROOF OF SERVICE
`In compliance with Rule 4.1(a) of the Rules of Procedure for the United States Judicial
`
`
`
`
`Panel on Multidistrict Litigation, I hereby certify that copies of the foregoing Notice of Appearance
`
`for Defendant Biocon Biologics Inc. and Defendant Mylan Pharmaceuticals Inc., Corporate
`
`Disclosure Statement for Defendant Biocon Biologics Inc., Corporate Disclosure Statement for
`
`Defendant Mylan Pharmaceuticals Inc., and Proof of Service were served by Email on January 26,
`
`2024 to the following:
`
`Counsel for Plaintiff Regeneron Pharmaceuticals Inc. (Served via Email)
`
`
`David I. Berl
`Ellen E. Oberwetter
`Thomas S. Fletcher
`Andrew V. Trask
`Teagan J. Gregory
`Shaun P. Mahaffy
`Kathryn S. Kayali
`Arthur J. Argall, III
`Adam Pan
`Rebecca A. Carter
`Haylee Bernal Anderson
`Renee M. Griffin
`Jennalee Beazley
`Rhochelle Krawetz
`Sean M. Douglass
`Nicholas Jordan
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, SW
`Washington, DC 20024
`dberl@wc.com
`eoberwetter@wc.com
`tfletcher@wc.com
`
`

`

`
`
`Case MDL No. 3103 Document 19-1 Filed 01/26/24 Page 2 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 21 of 62 PageID #: 2472
`
`
`
`atrask@wc.com
`tgregory@wc.com
`smahaffy@wc.com
`kkayali@wc.com
`aargall@wc.com
`apan@wc.com
`rebeccacarter@wc.com
`handerson@wc.com
`rgriffin@wc.com
`jbeazley@wc.com
`rkrawetz@wc.com
`sdouglass@wc.com
`njordan@wc.com
`
`Elizabeth S. Weiswasser
`Anish R. Desai
`Natalie C. Kennedy
`Tom Yu
`Yi Zhang
`Kathryn Leicht
`Rocco Recce
`Zhen Lin
`Kellie Van Beck
`Jennifer Melien Brooks Crozier
`WEIL GOTSHAL & MANGES LLP
`767 5th Avenue
`New York, NY 10153
`Elizabeth.Weiswasser@weil.com
`Anish.Desai@weil.com
`Natalie.Kennedy@weil.com
`Tom.Yu@weil.com
`Yi.Zhang@weil.com
`Kathryn.Leicht@weil.com
`Rocco.Recce@weil.com
`Zhen.Lin@weil.com
`Kellie.VanBeck@weil.com
`Jennifer.Crozier@weil.com
`
`Christopher M. Pepe
`Priyata Y. Patel
`Matthew Sieger
`WEIL GOTSHAL & MANGES LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`Christopher.Pepe@weil.com
`Priyata.Patel@weil.com
`
`

`

`
`
`Case MDL No. 3103 Document 19-1 Filed 01/26/24 Page 3 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 22 of 62 PageID #: 2473
`
`Matthew.Seiger@weil.com
`
`Andrew E. Goldsmith
`Jacob E. Hartman
`Evan T. Leo
`Mary Charlotte Y. Carroll
`Sven E. Henningson, III
`Grace W. Knofczynski
`KELLOGG, HANSEN, TODD, FIGEL & FREDERICK, P.L.L.C.
`1615 M Street, NW, Suite 400
`Washington, DC 20036
`agoldsmith@kellogghansen.com
`eleo@kellogghansen.com
`jhartman@kellogghansen.com
`mcarroll@kellogghansen.com
`shenningson@kellogghansen.com
`gknofczynski@kellogghansen.com
`
`Michael W. Carey
`Steven R. Ruby
`David R. Pogue
`Raymond S. Franks, II
`S. Benjamin Bryant
`CAREY DOUGLAS KESSLER & RUBY, PLLC
`707 Virginia Street East
`901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25353
`mwcarey@cdkrlawfirm.com
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`rfranks@cdkrlaw.com
`sbbryant@cdkrlaw.com
`
`Tony Bisconti
`BIENERT KATZMAN LITTRELL WILLIAMS LLP
`903 Calle Amanecer, Suite 350,
`San Clemente, CA 92673
`tbisconti@bklwlaw.com
`
`
`Counsel for Defendants by Proceeding (Served via Email) 1
`
`
`
`1 Counsel appearing on behalf of Defendant Biocon Biologics Inc. and Defendant Mylan
`Pharmaceuticals Inc. in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.,
`N.D. W. Va., C.A. No. 1:22-cv-00061-TSK-JPM are included in the signature block.
`
`

`

`
`
`Case MDL No. 3103 Document 19-1 Filed 01/26/24 Page 4 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 23 of 62 PageID #: 2474
`
`Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.,
`N.D. W. Va., C.A. No. 1:22-cv-00061-TSK-JPM
`
`
`Counsel for Defendant-Intervenor Amgen USA, Inc.
`
`
`John H. Tinney, Jr.
`HENDRICKSON & LONG, PLLC
`214 Capitol Street
`P.O. Box 11070 Charleston, WV 25301
`jtinney@handl.com
`
`
`Counsel for Defendant-Intervenor Celltrion, Inc.
`
`
`Laura C. Davis.
`MANCHIN FERRETTI, PLLC
`408 West King Street
`Martinsburg, WV 25401
`ldavis@wvjusticelawyers.com
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.,
`N.D. W. Va., C.A. No. 1:23-cv-00089-TSK
`
`
`Counsel for Defendant Celltrion, Inc.
`
`
`Robert Cerwinski
`Cindy Chang
`Michael Cottler
`Lora Green
`David Kim
`Brigid Morris
`Aviv Zalcenstein
`GEMINI LAW LLP
`40 W. 24th Street, Suite 6N
`New York, NY 10010
`rcerwinski@geminilaw.com
`cchang@geminilaw.com
`mcottler@geminilaw.com
`lgreen@geminilaw.com
`dkim@geminilaw.com
`bmorris@geminilaw.com
`azalcenstein@geminilaw.com
`
`Andrew C. Robey
`Carl Winfield Shaffer
`Max C. Gottlieb
`Michael B. Hissam
`
`

`

`
`
`Case MDL No. 3103 Document 19-1 Filed 01/26/24 Page 5 of 7Case 1:24-cv-00053-TSK Document 16-3 Filed 05/31/24 Page 24 of 62 PageID #: 2475
`
`HISSAM FORMAN DONOVAN RITCHIE PLLC
`707 Virginia Street, East, Suite 260
`Post Office Box 3983
`Charleston, WV 25301
`arobey@hfdrlaw.com
`cshaffer@hfdrlaw.com
`mgottlieb@hfdrlaw.com
`mhissam@hfdrlaw.com
`
`Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.,
`N.D. W. Va., C.A. No. 1:23-cv-00094-TSK & N.D. W. Va., C.A. No. 1:23-cv-00106-TSK
`
`
`
`
`
`
`Counsel for Defendant Samsung Bioepis Co. Ltd.
`
`
`Chad L. Taylor
`Frank E. Simmerman, Jr.
`Frank Edward Simmerman, III
`SIMMERMAN LAW OFFICE PLLC
`254 E Main St Clarksburg, WV 26301
`clt@simmermanlaw.com
`fes@simmermanlaw.com
`trey@simmermanlaw.com
`
`Laura L. Fairneny
`Matthew A. Traupman
`Raymond N. Nimrod
`Matthew D. Robson
`QUINN EMANUEL URQUHART & SULLIVAN, LL